Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Mycophenolate mofetil

2

I.b Pneumonitis (ILD)

1
Last update : 06/09/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Reversible diffuse lung disease after mycophenolate mofetil withdrawal.
Pulmonology 2018;24;361-362 2018
Unusual Case of Acute Lung Injury in a Renal Allograft Recipient.
Indian journal of nephrology 2017;27;215-217 2017
Reversible interstitial lung disease following treatment of atopic dermatitis with mycophenolate mofetil.
Clinical and experimental dermatology 2016 Aug;41;702-3 2016 Aug
Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy.
The Kaohsiung journal of medical sciences 2015 Jan;31;42-6 2015 Jan
Pneumonitis associated with the use of mycophenolate mofetil.
Transplantation 2003 May 27;75;1762 2003 May 27

Powered by

  • ^
  • Contact
  • Cookies
  • About